CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

FDA gains ‘continuity’ as Mikhail, Davis named permanent CBER, CDER leaders

RegulatoryPositive
AI Analysis

Summary

The FDA names Mikhail and Davis as permanent leaders of CBER and CDER respectively, providing continuity after nearly two years of leadership turnover at the agency.

Importance:3/10
Sentiment:
0.50
FDA leadershipCBERCDERregulatorymanagement

Read the original article

Published by BioPharma Dive on September 9, 2026 3:04 PM

Read Original